GR00016-A |
6714 |
6714 |
SRC |
np |
1.74 |
none |
|
no |
|
Wnt/beta-catenin pathway regulation |
Bruton's tyrosine kinase revealed as a negative regulator of Wnt-beta-catenin signaling. |
James et al. |
2009 |
19471023 |
Cell line |
RKO |
Wnt/beta-catenin pathway reporter |
Luminescence |
rp |
Selected genes |
siRNA |
Z-score |
> 2 |
|
GR00053-A |
6714 |
NM_005417 |
SRC |
np |
sp |
none |
|
no |
|
Genome stability |
A genome-wide siRNA screen reveals diverse cellular processes and pathways that mediate genome stability. |
Paulsen et al. |
2009 |
19647519 |
Cell line |
HeLa |
gamma-H2AX phosphorylation and DNA content |
Fluorescence |
siARRAY human genome siRNA library |
Genome-wide |
siRNA |
p-value |
Complex criteria |
Confidence groupings from 4 to 1 (highest level of confidence in group 4) |
GR00054-A |
6714 |
NM_005417 |
SRC |
np |
0.897 |
none |
|
no |
|
Combinatorial effect with paclitaxel |
Synthetic lethal screen identification of chemosensitizer loci in cancer cells. |
Whitehurst et al. |
2007 |
17429401 |
Cell line |
NCI-H1155 |
Viability (synthetic lethal) |
ATP level |
# G-005000-01 |
Genome-wide |
siRNA |
Paclitaxel/control ratio |
Complex criteria |
Additional information about 87 high-confidence hits |
|
6714 |
6714 |
SRC |
np |
np |
none |
|
no |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GR00056-A |
6714 |
NM_005417 |
SRC |
np |
1.012 |
none |
|
no |
|
Melanogenesis |
Genome-wide siRNA-based functional genomics of pigmentation identifies novel genes and pathways that impact melanogenesis in human cells. |
Ganesan et al. |
2008 |
19057677 |
Cell line |
MNT-1 |
Melanin protein expression and viability |
Absorbance and luminescence |
rp |
Genome-wide |
siRNA |
Normalized absorbance ratio |
> 2 standard deviations below mean |
Additional information about a secondary screen (retest to determine false-positive rate) |
GR00057-A-1 |
6714 |
NM_005417 |
SRC |
M-003175-03 |
2.72 |
none |
|
no |
|
Wnt/beta-catenin pathway regulation (1) |
A genome-wide RNAi screen for Wnt/beta-catenin pathway components identifies unexpected roles for TCF transcription factors in cancer. |
Tang et al. |
2008 |
18621708 |
Cell line |
HeLa |
Wnt pathway reporter |
Luminescence |
Human siArray siRNA library |
Genome-wide |
siRNA |
Z-score |
> 4 |
Screen without Wnt3A stimulation. Additional information about secondary screens (Dharmacon and Qiagen libraries). |
GR00057-A-2 |
6714 |
NM_005417 |
SRC |
M-003175-03 |
sp |
none |
|
no |
|
Wnt/beta-catenin pathway regulation (2) |
A genome-wide RNAi screen for Wnt/beta-catenin pathway components identifies unexpected roles for TCF transcription factors in cancer. |
Tang et al. |
2008 |
18621708 |
Cell line |
HeLa |
Wnt pathway reporter |
Luminescence |
Human siArray siRNA library |
Genome-wide |
siRNA |
Complex, SP |
Complex criteria |
Screen with Wnt3A stimulation. Additional information about secondary screens (Dharmacon and Qiagen libraries). |
GR00095-A |
6714 |
NM_005417 |
SRC |
np |
np |
none |
|
|
|
p53 pathway components |
A large-scale RNAi screen in human cells identifies new components of the p53 pathway |
Berns et al. |
2004 |
15042092 |
Cell line |
BJ-TERT-tsLT fibroblasts |
Proliferation |
Colony-forming cell assay |
Nki library |
Genome-wide |
shRNA |
np |
np |
|
GR00098-A-1 |
6714 |
ENSG00000197122 |
SRC |
ENSG00000197122 |
sp |
none |
|
no |
|
Cell division (1) |
Genome-scale RNAi profiling of cell division in human tissue culture cells. |
Kittler et al. |
2007 |
17994010 |
Cell line |
HeLa |
Cell number and DNA content |
Laser scanning cytometry |
rp |
Genome-wide |
esiRNA |
Complex, sp |
Complex criteria |
|
GR00105-A-0 |
6714 |
|
SRC |
np |
73% |
Decreased viability in CMK cells |
|
no |
|
Cell viability |
RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia. |
Tyner et al. |
2008 |
18025156 |
Cell line |
CMK, HMC1.1 (white blood cells) |
Cell viability |
Cell viability (CellTiter 96) |
Dharmacon (tyrosine kinases) |
|
siRNA |
% viability |
np |
|
GR00105-A-0 |
6714 |
|
SRC |
np |
68% |
Decreased viability in HMC1.1 cells |
|
no |
|
Cell viability |
RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia. |
Tyner et al. |
2008 |
18025156 |
Cell line |
CMK, HMC1.1 (white blood cells) |
Cell viability |
Cell viability (CellTiter 96) |
Dharmacon (tyrosine kinases) |
|
siRNA |
% viability |
np |
|
GR00113-A-0 |
6714 |
|
SRC |
np |
np |
Paclitaxel antagonistic effect |
|
no |
|
Anticancer drug enhancers |
Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs. |
Swanton et al. |
2007 |
17560332 |
Cell line |
A549, HCT116, MDA-MB-231 |
Cell viability |
ATP levels |
Dharmacon (kinases) |
|
siRNA |
np |
Significant effect in at least 2 of 3 cell lines |
|
GR00114-A |
6714 |
|
SRC |
np |
0.7 |
none |
|
|
85% |
Combinatorial effect with Poly (ADPâ€ribose)â€polymeraseâ€1 (PARP) |
A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor. |
Turner et al. |
2008 |
18388863 |
Cell line |
CAL51 |
Viability |
Luminescence |
siARRAY SMARTpool |
Kinases |
siRNA |
Z-score |
< |
Growth rates (%) for vehicle-alone experiments are given in the comment field. |
GR00123-A |
6714 |
NM_005417 |
SRC |
101773, 101772, 101771 |
np |
none |
|
|
|
Combinatorial effect with nutlin-3 |
An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors |
Brummelkamp et al. |
2006 |
16474381 |
Cell line |
MCF-7 |
Viability |
Fluoresence |
Nki library |
Genome-wide |
shRNA |
log2 ratio |
np |
|
GR00133-A-1 |
6714 |
6714 |
SRC |
np |
0.050603 |
none |
|
no |
|
Salmonella enterica subspecies 1 serovar Typhimurium invasion (1) |
RNAi screen of Salmonella invasion shows role of COPI in membrane targeting of cholesterol and Cdc42. |
Misselwitz et al. |
2011 |
21407211 |
Cell line |
HeLa |
Gentamycin protection invasion assay |
Fluorescence |
Druggable genome library V2.0 |
Druggable genes |
siRNA |
log2 median |
Complex criteria |
|
GR00143-A |
6714 |
|
SRC |
SRC s1 |
sp |
none |
|
no |
|
tau phosphorylation |
High-content siRNA screening of the kinome identifies kinases involved in Alzheimer's disease-related tau hyperphosphorylation. |
Azorsa et al. |
2010 |
20067632 |
Cell line |
H4 overexpressing 4RON tau |
Total tau and 12E8 tau protein expression |
Fluorescence |
Validated human kinase siRNA Set 2.0 |
Kinases |
siRNA |
p-value |
Complex criteria |
|
GR00143-A |
6714 |
|
SRC |
SRC s2 |
sp |
none |
|
no |
|
tau phosphorylation |
High-content siRNA screening of the kinome identifies kinases involved in Alzheimer's disease-related tau hyperphosphorylation. |
Azorsa et al. |
2010 |
20067632 |
Cell line |
H4 overexpressing 4RON tau |
Total tau and 12E8 tau protein expression |
Fluorescence |
Validated human kinase siRNA Set 2.0 |
Kinases |
siRNA |
p-value |
Complex criteria |
|
GR00149-A-1 |
6714 |
6714 |
SRC |
683 |
38.7 |
none |
|
no |
|
Ciliogenesis and cilium length (1) |
Functional genomic screen for modulators of ciliogenesis and cilium length. |
Kim et al. |
2010 |
20393563 |
Cell line |
htRPE |
Smoothed protein expression |
Fluorescence |
Human druggable genome siRNA library V3.1 |
Druggable genes |
siRNA |
Normalized percent inhibition |
> 1.5 OR < -1.5 standard deviations from mean |
|
GR00149-A-1 |
6714 |
6714 |
SRC |
683 |
23 |
none |
|
no |
|
Ciliogenesis and cilium length (1) |
Functional genomic screen for modulators of ciliogenesis and cilium length. |
Kim et al. |
2010 |
20393563 |
Cell line |
htRPE |
Smoothed protein expression |
Fluorescence |
Human druggable genome siRNA library V3.1 |
Druggable genes |
siRNA |
Normalized percent inhibition |
> 1.5 OR < -1.5 standard deviations from mean |
|
GR00149-A-1 |
6714 |
6714 |
SRC |
684 |
np |
none |
|
no |
|
Ciliogenesis and cilium length (1) |
Functional genomic screen for modulators of ciliogenesis and cilium length. |
Kim et al. |
2010 |
20393563 |
Cell line |
htRPE |
Smoothed protein expression |
Fluorescence |
Human druggable genome siRNA library V3.1 |
Druggable genes |
siRNA |
Normalized percent inhibition |
> 1.5 OR < -1.5 standard deviations from mean |
|
GR00149-A-1 |
6714 |
6714 |
SRC |
684 |
27.28 |
none |
|
no |
|
Ciliogenesis and cilium length (1) |
Functional genomic screen for modulators of ciliogenesis and cilium length. |
Kim et al. |
2010 |
20393563 |
Cell line |
htRPE |
Smoothed protein expression |
Fluorescence |
Human druggable genome siRNA library V3.1 |
Druggable genes |
siRNA |
Normalized percent inhibition |
> 1.5 OR < -1.5 standard deviations from mean |
|
GR00149-A-1 |
6714 |
6714 |
SRC |
103333 |
-173.1 |
none |
|
no |
|
Ciliogenesis and cilium length (1) |
Functional genomic screen for modulators of ciliogenesis and cilium length. |
Kim et al. |
2010 |
20393563 |
Cell line |
htRPE |
Smoothed protein expression |
Fluorescence |
Human druggable genome siRNA library V3.1 |
Druggable genes |
siRNA |
Normalized percent inhibition |
> 1.5 OR < -1.5 standard deviations from mean |
|
GR00149-A-1 |
6714 |
6714 |
SRC |
103333 |
-51.67 |
none |
|
no |
|
Ciliogenesis and cilium length (1) |
Functional genomic screen for modulators of ciliogenesis and cilium length. |
Kim et al. |
2010 |
20393563 |
Cell line |
htRPE |
Smoothed protein expression |
Fluorescence |
Human druggable genome siRNA library V3.1 |
Druggable genes |
siRNA |
Normalized percent inhibition |
> 1.5 OR < -1.5 standard deviations from mean |
|
GR00149-A-1 |
6714 |
6714 |
SRC |
103417 |
-55.38 |
none |
|
no |
|
Ciliogenesis and cilium length (1) |
Functional genomic screen for modulators of ciliogenesis and cilium length. |
Kim et al. |
2010 |
20393563 |
Cell line |
htRPE |
Smoothed protein expression |
Fluorescence |
Human druggable genome siRNA library V3.1 |
Druggable genes |
siRNA |
Normalized percent inhibition |
> 1.5 OR < -1.5 standard deviations from mean |
|
GR00149-A-1 |
6714 |
6714 |
SRC |
103417 |
-73.38 |
none |
|
no |
|
Ciliogenesis and cilium length (1) |
Functional genomic screen for modulators of ciliogenesis and cilium length. |
Kim et al. |
2010 |
20393563 |
Cell line |
htRPE |
Smoothed protein expression |
Fluorescence |
Human druggable genome siRNA library V3.1 |
Druggable genes |
siRNA |
Normalized percent inhibition |
> 1.5 OR < -1.5 standard deviations from mean |
|
GR00151-A-1 |
6714 |
ENSG00000197122 |
SRC |
np |
-0.847 |
none |
|
no |
|
Homologous recombination DNA double-strand break repair (HR-DSBR) (1) |
A genome-scale DNA repair RNAi screen identifies SPG48 as a novel gene associated with hereditary spastic paraplegia. |
Słabicki et al. |
2010 |
20613862 |
Cell line |
HeLa |
(HR-DSBR) DR-GFP reporter |
Flow cytometry |
Custom-made |
Genome-wide |
esiRNA |
Z-score |
< -2 OR > 2 |
|
GR00155-A |
6714 |
6714 |
SRC |
SRC_1, SRC_2, SRC_3 |
np |
none |
|
no |
|
Aryl hydrocarbon receptor (AhR) transduction pathway regulation |
RNAi-based screening identifies kinases interfering with dioxin-mediated up-regulation of CYP1A1 activity. |
Gilot et al. |
2011 |
21479225 |
Cell line |
MCF-7 |
TCDD-induced CYP1A1-related EROD activity and cell viability |
Fluorescence and methylene blue |
MISSION siRNA Human Kinase Panel library |
Kinases |
siRNA |
Z-score |
Top 150 for > |
|
GR00156-A |
6714 |
|
SRC |
np |
130.65 |
Increased telomerase activity |
|
yes |
|
Telomerase activity regulation |
High-throughput RNAi screening reveals novel regulators of telomerase. |
Cerone et al. |
2011 |
21531765 |
Cell line |
HeLa |
Telomerase activity |
Real-time qTRAP |
SMARTpool siRNA kinase library |
Kinases |
siRNA |
Percentage |
< 35 % OR > 150 % |
|
GR00156-A |
6714 |
|
SRC |
np |
155.92 |
Increased telomerase activity |
|
yes |
|
Telomerase activity regulation |
High-throughput RNAi screening reveals novel regulators of telomerase. |
Cerone et al. |
2011 |
21531765 |
Cell line |
HeLa |
Telomerase activity |
Real-time qTRAP |
SMARTpool siRNA kinase library |
Kinases |
siRNA |
Percentage |
< 35 % OR > 150 % |
|
GR00179-A-1 |
6714 |
|
SRC |
np |
0.276 |
Decreased viability with paclitaxel |
|
yes |
|
Combinatorial effect with paclitaxel (1) |
RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells. |
Bauer et al. |
2010 |
20576088 |
Cell line |
HeLa |
Viability (synthetic lethal) |
Alamar Blue |
pGIPZ shRNAmir plasmid library |
Selected genes |
shRNA |
Sensitivity index |
> 0.078 (> 3 shRNAs) OR > 0.15 (< |
|
GR00179-A-2 |
6714 |
|
SRC |
np |
np |
none |
|
no |
|
Combinatorial effect with paclitaxel (2) |
RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells. |
Bauer et al. |
2010 |
20576088 |
Cell line |
MDA-MB-231 |
Viability (synthetic lethal) |
Alamar Blue |
Custom-made |
Selected genes |
siRNA |
Sensitivity index |
Complex criteria |
|
GR00179-A-3 |
6714 |
|
SRC |
np |
np |
none |
|
no |
|
Combinatorial effect with paclitaxel (3) |
RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells. |
Bauer et al. |
2010 |
20576088 |
Cell line |
MDA-MB-468 |
Viability (synthetic lethal) |
Alamar Blue |
Custom-made |
Selected genes |
siRNA |
Sensitivity index |
Complex criteria |
|
GR00180-A-1 |
6714 |
6714 |
SRC |
PL-50003 |
0.207 |
none |
|
no |
|
Hepatitis C virus replication (1) |
A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. |
Tai et al. |
2009 |
19286138 |
Cell line |
Huh7/Rep-Feo |
HCV replicon RNA copy number |
Luminescence |
siARRAY Human Genome siRNA Library |
Genome-wide |
siRNA |
q-value |
Complex criteria |
|
GR00184-A-1 |
6714 |
NM_005417 |
SRC |
M-003175-03 |
0.347717457947569 |
none |
|
no |
|
Self-renewal and pluripotency in human embryonic stem cells (1) |
A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity. |
Chia et al. |
2010 |
20953172 |
Cell line |
hESC H1 |
POU5F1 protein expression |
Fluorescence |
SMARTpool siRNA library |
Genome-wide |
siRNA |
Z-score |
< -2 |
|
GR00193-A-1 |
6714 |
6714 |
SRC |
SRC |
0.653 |
none |
|
yes |
Illumina gene expression above basal level (p < 0.05) |
Therapeutic kinase targets in neuroblastoma (1) |
RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma. |
Cole et al. |
2011 |
21289283 |
Cell line |
EBC1 |
Substrate adherent cell growth |
rp |
Kinase siGenome library |
Kinases |
siRNA |
Relative growth |
0.5 standard deviations below mean |
|
GR00193-A-2 |
6714 |
6714 |
SRC |
SRC |
0.735847399746317 |
none |
|
yes |
|
Therapeutic kinase targets in neuroblastoma (2) |
RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma. |
Cole et al. |
2011 |
21289283 |
Cell line |
KELLY |
Substrate adherent cell growth |
rp |
Kinase siGenome library |
Kinases |
siRNA |
Relative growth |
0.5 standard deviations below mean |
|
GR00193-A-3 |
6714 |
6714 |
SRC |
SRC |
1.02649995541801 |
none |
|
yes |
Illumina gene expression above basal level (p < 0.05) |
Therapeutic kinase targets in neuroblastoma (3) |
RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma. |
Cole et al. |
2011 |
21289283 |
Cell line |
SKNAS |
Substrate adherent cell growth |
rp |
Kinase siGenome library |
Kinases |
siRNA |
Relative growth |
0.5 standard deviations below mean |
|
GR00193-A-4 |
6714 |
6714 |
SRC |
SRC |
0.983347642834842 |
none |
|
no |
Illumina gene expression above basal level (p < 0.05) |
Therapeutic kinase targets in neuroblastoma (4) |
RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma. |
Cole et al. |
2011 |
21289283 |
Cell line |
NLF |
Substrate adherent cell growth |
rp |
Kinase siGenome library |
Kinases |
siRNA |
Relative growth |
0.5 standard deviations below mean |
|
GR00196-A-1 |
6714 |
ENSG00000197122 |
|
np |
sp |
none |
|
no |
|
TP53 interactions (1) |
A systematic RNAi synthetic interaction screen reveals a link between p53 and snoRNP assembly. |
Krastev et al. |
2011 |
21642980 |
Cell line |
HCT116 ( wildtype and TP53 knockout) |
TP53 protein expression and viability |
Fluorescence |
rp |
Genome-wide |
esiRNA |
Complex, sp |
Complex criteria |
|
GR00197-A-1 |
6714 |
6714 |
SRC |
M-003175-03 |
-0.693090096 |
none |
|
no |
|
Human papillomavirus oncogene expression regulation (1) |
Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. |
Smith et al. |
2010 |
20133580 |
Cell line |
C33A/BE2/18LCR c4 |
HPV18 LCR reporter activity |
Luminescence |
Human siGENOME SMARTpool library |
Genome-wide |
siRNA |
Z-score |
> |
Author-submitted data. Phenotype strength according to Z-scores: weak: 2 - 3; moderate: 3 - 5; strong: > 5 |
GR00206-A |
6714 |
6714 |
SRC |
np |
np |
none |
|
no |
|
Apoptosis regulation after Chlamydia trachomatis serovar L2 infection |
HIF-1α is involved in mediating apoptosis resistance to Chlamydia trachomatis-infected cells. |
Sharma et al. |
2011 |
21824245 |
Cell line |
HeLa |
Cleaved cytokeratin-18 protein expression |
Fluorescence |
Custom-made |
Apoptosis, cellular trafficking and cell signalling genes |
siRNA |
p-value |
< |
Author-reviewed data |
GR00210-A |
6714 |
6714 |
SRC |
np |
sp |
none |
|
no |
|
Focal adhesion formation |
Multiparametric analysis of focal adhesion formation by RNAi-mediated gene knockdown. |
Winograd-Katz et al. |
2009 |
19667130 |
Cell line |
HeLa |
paxillin protein expression |
Fluorescence |
SMARTpool siARRAY siRNA Libraries |
Kinases, phosphatases and selected genes |
siRNA |
Z-score |
> 3.5 OR < -3.5 |
|
GR00225-A |
6714 |
|
SRC |
SRC_A |
-0.12052 |
none |
5nM gemcitabine |
no |
|
Combinatorial effect with gemcitabine |
Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer. |
Azorsa et al. |
2009 |
19519883 |
Cell line |
MIAPaCa-2 |
Viability (synthetic lethal) |
Luminescence |
Validated kinase siRNA library version 1.0 |
Kinases |
siRNA |
log2 ratio |
1.65 SD below mean ratio level |
|
GR00225-A |
6714 |
|
SRC |
SRC_B |
-0.37336 |
none |
5nM gemcitabine |
no |
|
Combinatorial effect with gemcitabine |
Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer. |
Azorsa et al. |
2009 |
19519883 |
Cell line |
MIAPaCa-2 |
Viability (synthetic lethal) |
Luminescence |
Validated kinase siRNA library version 1.0 |
Kinases |
siRNA |
log2 ratio |
1.65 SD below mean ratio level |
|
GR00225-A |
6714 |
|
SRC |
SRC_A |
-1.038468 |
none |
10nM gemcitabine |
no |
|
Combinatorial effect with gemcitabine |
Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer. |
Azorsa et al. |
2009 |
19519883 |
Cell line |
MIAPaCa-2 |
Viability (synthetic lethal) |
Luminescence |
Validated kinase siRNA library version 1.0 |
Kinases |
siRNA |
log2 ratio |
1.65 SD below mean ratio level |
|
GR00225-A |
6714 |
|
SRC |
SRC_B |
-0.758283 |
none |
10nM gemcitabine |
no |
|
Combinatorial effect with gemcitabine |
Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer. |
Azorsa et al. |
2009 |
19519883 |
Cell line |
MIAPaCa-2 |
Viability (synthetic lethal) |
Luminescence |
Validated kinase siRNA library version 1.0 |
Kinases |
siRNA |
log2 ratio |
1.65 SD below mean ratio level |
|
|
6714 |
NM_198291 |
SRC |
np |
1.1067 |
none |
|
no |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GR00231-A |
6714 |
NM_005417 |
SRC |
M-003175-03 |
0.074 |
none |
|
yes |
|
Cell proliferation |
Time-resolved human kinome RNAi screen identifies a network regulating mitotic-events as early regulators of cell proliferation. |
Zhang et al. |
2011 |
21765947 |
Cell line |
HeLa |
Viability |
Electrical impedance |
Human siARRAY - Protein Kinase and Cell Cycle libraries |
Kinases and selected genes |
siRNA |
Z-score |
< -1.96 OR > 1.96 |
Additional information about cell titer blue cell viability screen |
GR00234-A-1 |
6714 |
NM_005417 |
SRC |
np |
sp |
none |
|
no |
|
Hepatitis C virus (HCV) infection (1) |
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. |
Lupberger et al. |
2011 |
21516087 |
Cell line |
Huh7 |
Hepatitis C Virus pseudoparticles (HCVpp; H77; genotype 1a) protein expression |
Luminescence |
Human Kinase RNAi Set V2.0 |
Kinases |
siRNA |
Complex, sp |
Complex criteria |
|
GR00236-A-1 |
6714 |
6714 |
SRC |
M-003175-03 |
1.01197187310279 |
none |
|
no |
|
Homologous recombination DNA double-strand break repair (HR-DSBR) (1) |
A genome-wide homologous recombination screen identifies the RNA-binding protein RBMX as a component of the DNA-damage response. |
Adamson et al. |
2012 |
22344029 |
Cell line |
DR-U2OS |
(HR-DSBR) DR-GFP reporter and DNA content |
Fluorescence |
Human siGENOME siRNA (G-005000-05) |
Genome-wide |
siRNA |
Relative HR ratio |
< ~0.4 OR > 1.88 |
Cutoff values correspond 2 standard deviations from the screen-wide mean |
GR00240-S-1 |
6714 |
NM_005417 |
SRC |
M-003175-03 |
-0.61 |
none |
|
yes |
|
TRAIL-induced apoptosis (1) |
A synthetic lethal screen identifies FAT1 as an antagonist of caspase-8 in extrinsic apoptosis. |
Kranz and Boutros |
2014 |
24442637 |
Cell line |
U251MG |
Viability |
Luminescence |
SMART-pool siRNA |
Genome-wide |
siRNA |
Z-score |
> 4 |
Author-submitted data |
GR00240-S-2 |
6714 |
NM_005417 |
SRC |
M-003175-03 |
-0.36 |
none |
|
no |
Z-score -0.833 |
TRAIL-induced apoptosis (2) |
A synthetic lethal screen identifies FAT1 as an antagonist of caspase-8 in extrinsic apoptosis. |
Kranz and Boutros |
2014 |
24442637 |
Cell line |
U251MG |
Viability (synthetic lethal) |
Luminescence |
SMART-pool siRNA |
Genome-wide |
siRNA |
Differential score |
> 3.6 AND viability Z-score < 4 |
Author-submitted data. Z-scores from viability screen (1) are considered in score interpretation for this screen. |
GR00242-A-1 |
6714 |
NM_005417 |
SRC |
np |
sp |
none |
|
no |
|
Selective autophagy regulation (1) |
Image-based genome-wide siRNA screen identifies selective autophagy factors. |
Orvedahl et al. |
2011 |
22020285 |
Cell line |
HeLa/GFP-LC3 |
Sindbis virus (SIN) capsid SIN-mCherry.capsid and autophagosome GFP–LC3 protein expression |
Fluorescence |
siGenome |
Genome-wide |
siRNA |
Z-score |
Complex criteria |
|
GR00247-A-1 |
6714 |
|
SRC |
np |
sp |
none |
|
|
rank: 1451 |
Regulation of FOXO1 nuclear localization (1) |
Whole genome siRNA cell-based screen links mitochondria to Akt signaling network through uncoupling of electron transport chain. |
Senapedis et al. |
2011 |
21460183 |
Cell line |
U2OS |
EGFP-FOXO1a protein expression and DNA content |
Fluorescence |
Human Genome library |
Genome-wide |
siRNA |
Complex, sp |
Complex criteria |
|
GR00248-A |
6714 |
NM_005417 |
SRC |
SRC_siRNA1 |
1.457 |
none |
|
|
|
Human cytomegalovirus (HCMV) strain AD169 replication |
Human kinome profiling identifies a requirement for AMP-activated protein kinase during human cytomegalovirus infection. |
Terry et al. |
2012 |
22315427 |
Cell line |
MRC5 |
Human cytomegalovirus (HCMV) IE1 protein expression |
Fluorescence |
Mission siRNA Human Kinase Panel |
Kinases |
siRNA |
Z-score |
> |
|
GR00248-A |
6714 |
NM_005417 |
SRC |
SRC_siRNA2 |
0.053 |
none |
|
|
|
Human cytomegalovirus (HCMV) strain AD169 replication |
Human kinome profiling identifies a requirement for AMP-activated protein kinase during human cytomegalovirus infection. |
Terry et al. |
2012 |
22315427 |
Cell line |
MRC5 |
Human cytomegalovirus (HCMV) IE1 protein expression |
Fluorescence |
Mission siRNA Human Kinase Panel |
Kinases |
siRNA |
Z-score |
> |
|
GR00248-A |
6714 |
NM_005417 |
SRC |
SRC_siRNA3 |
-1.151 |
none |
|
|
|
Human cytomegalovirus (HCMV) strain AD169 replication |
Human kinome profiling identifies a requirement for AMP-activated protein kinase during human cytomegalovirus infection. |
Terry et al. |
2012 |
22315427 |
Cell line |
MRC5 |
Human cytomegalovirus (HCMV) IE1 protein expression |
Fluorescence |
Mission siRNA Human Kinase Panel |
Kinases |
siRNA |
Z-score |
> |
|
GR00249-S |
6714 |
6714 |
SRC |
J-003175-13 |
-0.28354 |
none |
|
no |
number of cells compared to control (%): 71.75 |
Vaccinia virus (VACV) infection |
Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. |
Sivan et al. |
2013 |
23401514 |
Cell line |
HeLa |
Vaccinia virus VACV IHD-J/GFP protein expression and DNA content |
Fluorescence |
Silencer Select Version 4, siGENOME SMARTpool and OnTargetPlus |
Genome-wide |
siRNA |
Z-score |
> |
Author-submitted data. Primary screen. Decreased viability phenotype if number of cells compared to control < 50 %. |
GR00249-S |
6714 |
6714 |
SRC |
M-003175-03 |
0.27826 |
none |
|
no |
number of cells compared to control (%): 70.49 |
Vaccinia virus (VACV) infection |
Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. |
Sivan et al. |
2013 |
23401514 |
Cell line |
HeLa |
Vaccinia virus VACV IHD-J/GFP protein expression and DNA content |
Fluorescence |
Silencer Select Version 4, siGENOME SMARTpool and OnTargetPlus |
Genome-wide |
siRNA |
Z-score |
> |
Author-submitted data. Primary screen. Decreased viability phenotype if number of cells compared to control < 50 %. |
GR00249-S |
6714 |
6714 |
SRC |
s13412 |
0.63437 |
none |
|
no |
number of cells compared to control (%): 90.36 |
Vaccinia virus (VACV) infection |
Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. |
Sivan et al. |
2013 |
23401514 |
Cell line |
HeLa |
Vaccinia virus VACV IHD-J/GFP protein expression and DNA content |
Fluorescence |
Silencer Select Version 4, siGENOME SMARTpool and OnTargetPlus |
Genome-wide |
siRNA |
Z-score |
> |
Author-submitted data. Primary screen. Decreased viability phenotype if number of cells compared to control < 50 %. |
GR00249-S |
6714 |
6714 |
SRC |
s13413 |
-0.44611 |
none |
|
no |
number of cells compared to control (%): 75.89 |
Vaccinia virus (VACV) infection |
Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. |
Sivan et al. |
2013 |
23401514 |
Cell line |
HeLa |
Vaccinia virus VACV IHD-J/GFP protein expression and DNA content |
Fluorescence |
Silencer Select Version 4, siGENOME SMARTpool and OnTargetPlus |
Genome-wide |
siRNA |
Z-score |
> |
Author-submitted data. Primary screen. Decreased viability phenotype if number of cells compared to control < 50 %. |
GR00249-S |
6714 |
6714 |
SRC |
s13414 |
-0.04544 |
none |
|
no |
number of cells compared to control (%): 74.41 |
Vaccinia virus (VACV) infection |
Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. |
Sivan et al. |
2013 |
23401514 |
Cell line |
HeLa |
Vaccinia virus VACV IHD-J/GFP protein expression and DNA content |
Fluorescence |
Silencer Select Version 4, siGENOME SMARTpool and OnTargetPlus |
Genome-wide |
siRNA |
Z-score |
> |
Author-submitted data. Primary screen. Decreased viability phenotype if number of cells compared to control < 50 %. |
GR00253-A |
6714 |
NM_005417 |
SRC |
np |
-0.257 |
none |
|
|
|
hepcidin regulation |
Unbiased RNAi screen for hepcidin regulators links hepcidin suppression to proliferative Ras/RAF and nutrient-dependent mTOR signaling. |
Mleczko-Sanecka et al. |
2014 |
24385536 |
Cell line |
Huh7 |
hepcidin::fluc mRNA expression |
Luminescence |
siGenome siARRAY SMARTpool |
Genome-wide |
siRNA |
Z-score |
> |
Cutoff < |
GR00255-A-1 |
6714 |
6714 |
SRC |
TRCN0000038149, TRCN0000038150, TRCN0000038151, TRCN0000038152, TRCN0000038153 |
-0.020681834 |
none |
|
|
|
Negative genetic interactions (1) |
A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities. |
Vizeacoumar et al. |
2013 |
24104479 |
Cell line |
HCT116 |
shRNA abundance |
Microarray |
np |
Genome-wide |
shRNA |
differential Gene Activity Ranking Profile (dGARP) |
< -1.0 |
HCT116 BLM-/- and HCT116 BLM+/+ cells used. Cutoff corresponds to p-value < 0.05. Additional information about a secondary screen (genetic interactions with Cetuximab/Erbitux in LIM1215 cells) |
GR00255-A-2 |
6714 |
6714 |
SRC |
TRCN0000038149, TRCN0000038150, TRCN0000038151, TRCN0000038152, TRCN0000038153 |
-0.152821768 |
none |
|
|
|
Negative genetic interactions (2) |
A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities. |
Vizeacoumar et al. |
2013 |
24104479 |
Cell line |
HCT116 |
shRNA abundance |
Microarray |
np |
Genome-wide |
shRNA |
differential Gene Activity Ranking Profile (dGARP) |
< -1.0 |
HCT116 MUS81-/- and HCT116 MUS81+/+ cells used. Cutoff corresponds to p-value < 0.05. Additional information about a secondary screen (genetic interactions with Cetuximab/Erbitux in LIM1215 cells) |
GR00255-A-3 |
6714 |
6714 |
SRC |
TRCN0000038149, TRCN0000038150, TRCN0000038151, TRCN0000038152, TRCN0000038153 |
0.632532113 |
none |
|
|
|
Negative genetic interactions (3) |
A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities. |
Vizeacoumar et al. |
2013 |
24104479 |
Cell line |
HCT116 |
shRNA abundance |
Microarray |
np |
Genome-wide |
shRNA |
differential Gene Activity Ranking Profile (dGARP) |
< -1.2 |
HCT116 PTEN-/- and HCT116 PTEN+/+ cells used. Cutoff corresponds to p-value < 0.05. Additional information about a secondary screen (genetic interactions with Cetuximab/Erbitux in LIM1215 cells) |
GR00255-A-4 |
6714 |
6714 |
SRC |
TRCN0000038149, TRCN0000038150, TRCN0000038151, TRCN0000038152, TRCN0000038153 |
-0.462314629 |
none |
|
|
|
Negative genetic interactions (4) |
A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities. |
Vizeacoumar et al. |
2013 |
24104479 |
Cell line |
HCT116 |
shRNA abundance |
Microarray |
np |
Genome-wide |
shRNA |
differential Gene Activity Ranking Profile (dGARP) |
< -1.2 |
HCT116 PTTG1-/- and HCT116 PTTG1+/+ cells used. Cutoff corresponds to p-value < 0.05. Additional information about a secondary screen (genetic interactions with Cetuximab/Erbitux in LIM1215 cells) |
GR00255-A-5 |
6714 |
6714 |
SRC |
TRCN0000038149, TRCN0000038150, TRCN0000038151, TRCN0000038152, TRCN0000038153 |
-0.36750031 |
none |
|
|
|
Negative genetic interactions (5) |
A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities. |
Vizeacoumar et al. |
2013 |
24104479 |
Cell line |
HCT116 |
shRNA abundance |
Microarray |
np |
Genome-wide |
shRNA |
differential Gene Activity Ranking Profile (dGARP) |
< -0.8 |
HCT116 KRASG13D/- and HCT116 KRAS+/- cells used. Cutoff corresponds to p-value < 0.05. Additional information about a secondary screen (genetic interactions with Cetuximab/Erbitux in LIM1215 cells) |
GR00256-A |
6714 |
NM_005417, NM_198291 |
SPHK2 |
np |
sp |
none |
|
|
|
Kinase-mediated spindle orientation |
ABL1 regulates spindle orientation in adherent cells and mammalian skin. |
Matsumara et al. |
2012 |
22252550 |
Cell line |
HeLa |
beta-tubulin protein expression and DNA content |
Fluorescence |
Silencer Kinase siRNA library (AM80010V3) |
Kinases |
siRNA |
Complex, sp |
Complex criteria |
HeLa cells stably expressing GFP-H2B (HeLa-GH2B) used. Additional information about secondary screens. |
GR00293-A |
6714 |
|
SRC |
np |
2.29 |
none |
|
|
|
Combinatorial effect with paclitaxel |
Mechanisms Promoting Escape from Mitotic Stress−Induced Tumor Cell Death |
Sinnott et al. |
2014 |
24860162 |
Cell line |
HCC366 |
Viability |
Luminescence |
Thermo-Fisher |
Genome-wide |
siRNA |
Z-score |
< -2.5 |
Final hits according to the author are indicated in the comment. |
GR00300-A |
6714 |
|
SRC |
TRCN0000199186, TRCN0000038149, TRCN0000038151, TRCN0000038150, TRCN0000038153, TRCN0000199313, TRCN0000038152, TRCN0000195339, TRCN0000196395 |
0 |
none |
|
|
|
Combinatorial effect with RAF inhibitor PLX4720 |
A genome-scale RNA interference screen implicates NF1 loss in resistance to RAF inhibition. |
Whittaker et al. |
2013 |
23288408 |
Cell line |
A375 |
shRNA abundance |
Sequencing |
TRC |
Genome-wide |
shRNA |
Number of shRNAs ranked Top1000 |
> 2 |
The A375 cell line used here harbours the BRAF V600E mutation and is therefore sensitive to RAF inhibitors. |
|
6714 |
NM_198291 |
SRC |
NM_198291.1-648s1c1 |
-1.8 |
Decreased viability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GR00303-A |
6714 |
NM_005417 |
SRC |
np |
-0.97 |
none |
|
|
|
Clear cell renal cell carcinoma (ccRCC) survival regulation |
Genome-wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic target |
Gerlinger et al. |
2012 |
22362593 |
Cell line |
VHL-deficient RCC4 |
Proliferation and Viability |
Fluorescence |
np |
Genome-wide |
siRNA |
Z-score |
< |
In the phenotype data duplicates were in the original document, which have been removed. |
GR00310-A-1 |
6714 |
6714 |
SRC |
np |
0.66 |
none |
|
|
|
Sindbis virus (SINV) infection (1) |
Genome-Wide RNAi Screen Identifies Novel Host Proteins Required for Alphavirus Entry |
Ooi et al. |
2013 |
24367265 |
Cell line |
U2OS |
Sindbis virus (SINV) reporter |
Luminescence |
Ambion Silencer V3 |
Genome-wide |
siRNA |
Z-score |
< -3 OR > 2 |
|
|
6714 |
6714 |
SRC |
np |
13.8 |
none |
|
|
107,6% viability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GR00313-A |
6714 |
NM_005417, NM_198291 |
SRC |
np |
-0.52 |
none |
|
|
|
TNF-alpha pathway regulation |
A Genome-Wide RNA Interference Screen Identifies Caspase 4 as a Factor Required for Tumor Necrosis Factor Alpha Signaling. |
Nickles et al. |
2012 |
22733992 |
Cell line |
HEK293T |
NFkappaB pathway reporter |
Luminescence |
Qiagen |
Genome-wide |
siRNA |
Z-score |
< |
Additional filters were a reduction in firefly luciferase levels by at least 50% compared to the mean of the experiment and a concomitant reduction of renilla luciferase expression of not more than 30%. |
GR00318-A |
6714 |
6714 |
SRC |
np |
1.099 |
none |
|
|
siRNA set: kinase |
Huntingtin toxicity |
A Genome-Scale RNA–Interference Screen Identifies RRAS Signaling as a Pathologic Feature of Huntington’s Disease |
Miller et al. |
2012 |
23209424 |
Cell line |
HEK293T |
Caspase 3/7 activity |
Fluorescence |
Dharmacon |
Selected genes |
siRNA |
Sum of normalized caspase 3/7 activity mean and standard error |
< 0.683 |
HEK293T cells were cotransfected with mutant Huntingtin fused to GFP (Htt1-558141Q-GFP). |
GR00342-S-1 |
6714 |
|
SRC |
M-003175-03 |
0.1666297531680972 |
none |
|
|
|
Viability of Mesenchymal Stem Cells (MSC) (1) |
Functional fingerprinting of human mesenchymal stem cells using high-throughput RNAi screening |
Erdmann et al. |
2015 |
26120366 |
Primary cells |
Bone marrow derived MSC |
Viability |
Luminescence |
Kinase siGENOME SMARTpool library |
Kinases and phosphatases |
siRNA |
Z-score |
> |
Donor 1, MSC preparation 1 (MSC1a) |
GR00342-S-2 |
6714 |
|
SRC |
M-003175-03 |
0.897859222042205 |
none |
|
|
|
Viability of Mesenchymal Stem Cells (MSC) (2) |
Functional fingerprinting of human mesenchymal stem cells using high-throughput RNAi screening |
Erdmann et al. |
2015 |
26120366 |
Primary cells |
Bone marrow derived MSC |
Viability |
Luminescence |
Kinase siGENOME SMARTpool library |
Kinases and phosphatases |
siRNA |
Z-score |
> |
Donor 1, MSC preparation 2 (MSC1b) |
GR00342-S-3 |
6714 |
|
SRC |
M-003175-03 |
-0.5967335082545376 |
none |
|
|
|
Viability of Mesenchymal Stem Cells (MSC) (3) |
Functional fingerprinting of human mesenchymal stem cells using high-throughput RNAi screening |
Erdmann et al. |
2015 |
26120366 |
Primary cells |
Bone marrow derived MSC |
Viability |
Luminescence |
Kinase siGENOME SMARTpool library |
Kinases and phosphatases |
siRNA |
Z-score |
> |
Donor 2, MSC preparation 1 (MSC2) |
GR00343-S |
6714 |
6714 |
SRC |
TRCN0000038150 |
0.5274999999999999 |
none |
|
|
|
Lentiviral shRNA "Achilles Heel" screen |
Inhibition of the mitochondrial protease, ClpP, as a therapeutic strategy for human acute myeloid leukemia |
Cole et al. |
2015 |
26058080 |
Cell line |
K562 |
shRNA abundance |
Fluorescence |
Lentiviral shRNA library |
Genome-wide |
shRNA |
Log2 ratio |
< |
Comparison of day 21 vs. day 0 abundance data |
GR00343-S |
6714 |
6714 |
SRC |
TRCN0000038153 |
0.23499999999999766 |
none |
|
|
|
Lentiviral shRNA "Achilles Heel" screen |
Inhibition of the mitochondrial protease, ClpP, as a therapeutic strategy for human acute myeloid leukemia |
Cole et al. |
2015 |
26058080 |
Cell line |
K562 |
shRNA abundance |
Fluorescence |
Lentiviral shRNA library |
Genome-wide |
shRNA |
Log2 ratio |
< |
Comparison of day 21 vs. day 0 abundance data |
GR00343-S |
6714 |
6714 |
SRC |
TRCN0000038149 |
0.6975000000000016 |
none |
|
|
|
Lentiviral shRNA "Achilles Heel" screen |
Inhibition of the mitochondrial protease, ClpP, as a therapeutic strategy for human acute myeloid leukemia |
Cole et al. |
2015 |
26058080 |
Cell line |
K562 |
shRNA abundance |
Fluorescence |
Lentiviral shRNA library |
Genome-wide |
shRNA |
Log2 ratio |
< |
Comparison of day 21 vs. day 0 abundance data |
GR00343-S |
6714 |
6714 |
SRC |
TRCN0000038152 |
0.10500000000000043 |
none |
|
|
|
Lentiviral shRNA "Achilles Heel" screen |
Inhibition of the mitochondrial protease, ClpP, as a therapeutic strategy for human acute myeloid leukemia |
Cole et al. |
2015 |
26058080 |
Cell line |
K562 |
shRNA abundance |
Fluorescence |
Lentiviral shRNA library |
Genome-wide |
shRNA |
Log2 ratio |
< |
Comparison of day 21 vs. day 0 abundance data |
GR00343-S |
6714 |
6714 |
SRC |
TRCN0000038151 |
1.7274999999999983 |
none |
|
|
|
Lentiviral shRNA "Achilles Heel" screen |
Inhibition of the mitochondrial protease, ClpP, as a therapeutic strategy for human acute myeloid leukemia |
Cole et al. |
2015 |
26058080 |
Cell line |
K562 |
shRNA abundance |
Fluorescence |
Lentiviral shRNA library |
Genome-wide |
shRNA |
Log2 ratio |
< |
Comparison of day 21 vs. day 0 abundance data |
GR00356-A-1 |
6714 |
NM_005417 |
SRC |
np |
0.8 |
none |
|
|
|
Clathrin-mediated endocytosis |
Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis. |
Pelkmans et al. |
2005 |
15889048 |
Cell line |
HeLa |
Vesicular stomatitis virus (VSV) infection (rVSV–GFP expression) |
Fluorescence |
Ambion |
Kinases |
siRNA |
Relative infection index (RII) |
< |
The cutoff was < 0.4 OR > 2.5 if the gene also scored in the additional screen "Caveolin- and lipid raft-mediated endocytosis" using simian virus 40 (SV40). |
GR00356-A-2 |
6714 |
NM_005417 |
SRC |
np |
0.0588381799995253 |
Decreased simian virus 40 (SV40) infection |
|
|
|
Caveolin- and lipid raft-mediated endocytosis |
Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis. |
Pelkmans et al. |
2005 |
15889048 |
Cell line |
HeLa |
Simian virus 40 (SV40) infection (SV40 large T-antigen expression) |
Fluorescence |
Ambion |
Kinases |
siRNA |
Relative infection index (RII) |
< |
The cutoff was < 0.4 OR > 2.5 if the gene also scored in the additional screen "Clathrin-mediated endocytosis" using vesicular stomatitis virus (VSV). |
GR00356-A-3 |
6714 |
NM_005417 |
SRC |
np |
np |
none |
|
|
|
Endocytosis regulation |
Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis. |
Pelkmans et al. |
2005 |
15889048 |
Cell line |
HeLa |
Transferrin (Tfn) uptake and trafficking |
Fluorescence |
Ambion |
Kinases |
siRNA |
np |
np |
|
|
6714 |
6714 |
SRC |
|
0 |
none |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GR00371-A-1 |
6714 |
6714 |
SRC |
|
-0.254548128055 |
none |
|
|
Dharmacon |
Nanog expression in absence of bFGF and TGFbeta |
Deterministic Restriction on Pluripotent State Dissolution by Cell-Cycle Pathways |
Gonzales et al. |
2015 |
26232226 |
Cell line |
NANOG-GFP H1 hESC |
NANOG expression |
Fluorescence |
Dharmacon and Ambion |
Selected genes |
siRNA |
Z-score |
>1,25 OR >1,5 [in at least two replicates] |
Z-score shown is an average of the z-scores from the three replicates performed for each gene. In the "Comment" field, the siRNA library used for each particular gene is noted. |
GR00371-A-2 |
6714 |
SRC |
6714 |
|
0.0109230720335 |
none |
|
|
Dharmacon |
Nanog expression in presence of TGFbeta inhibitor |
Deterministic Restriction on Pluripotent State Dissolution by Cell-Cycle Pathways |
Gonzales et al. |
2015 |
26232226 |
Cell line |
NANOG-GFP H1 hESC |
NANOG expression |
Fluorescence |
Dharmacon and Ambion |
Selected genes |
siRNA |
Z-score |
>1,25 OR >1,5 [in at least two replicates] |
Z-score shown is an average of the z-scores from the three replicates performed for each gene. In the "Comment" field, the siRNA library used for each particular gene is noted. |
GR00371-A-3 |
6714 |
6714 |
SRC |
|
-0.0315400458444 |
none |
|
|
Dharmacon |
Nanog expression in presence of MEK inhibitor |
Deterministic Restriction on Pluripotent State Dissolution by Cell-Cycle Pathways |
Gonzales et al. |
2015 |
26232226 |
Cell line |
NANOG-GFP H1 hESC |
NANOG expression |
Fluorescence |
Dharmacon and Ambion |
Selected genes |
siRNA |
Z-score |
>1,25 OR >1,5 [in at least two replicates] |
Z-score shown is an average of the z-scores from the three replicates performed for each gene. In the "Comment" field, the siRNA library used for each particular gene is noted. |
GR00371-A-4 |
6714 |
6714 |
SRC |
|
0.217864411523 |
none |
|
|
Dharmacon |
Nanog expression in presence of PI3K inhibitor |
Deterministic Restriction on Pluripotent State Dissolution by Cell-Cycle Pathways |
Gonzales et al. |
2015 |
26232226 |
Cell line |
NANOG-GFP H1 hESC |
NANOG expression |
Fluorescence |
Dharmacon and Ambion |
Selected genes |
siRNA |
Z-score |
>1,25 OR >1,5 [in at least two replicates] |
Z-score shown is an average of the z-scores from the three replicates performed for each gene. In the "Comment" field, the siRNA library used for each particular gene is noted. |
GR00371-A-5 |
6714 |
6714 |
SRC |
|
-0.217729745219 |
none |
|
|
Dharmacon |
Nanog expression in presence of retinoic acid |
Deterministic Restriction on Pluripotent State Dissolution by Cell-Cycle Pathways |
Gonzales et al. |
2015 |
26232226 |
Cell line |
NANOG-GFP H1 hESC |
NANOG expression |
Fluorescence |
Dharmacon and Ambion |
Selected genes |
siRNA |
Z-score |
>1,25 OR >1,5 [in at least two replicates] |
Z-score shown is an average of the z-scores from the three replicates performed for each gene. In the "Comment" field, the siRNA library used for each particular gene is noted. |
GR00376-A-1 |
6714 |
6714 |
SRC |
|
0.695468488 |
none |
|
|
|
Mitigators of SS1P-induced immunotoxicity |
Whole-genome RNAi screen highlights components of the endoplasmic reticulum/Golgi as a source of resistance to immunotoxin-mediated cytotoxicity |
Pasetto et al. |
2015 |
25713356 |
Cell line |
KB cells |
Viability |
Luminescence |
Ambion Silencer Select Version 4 |
Genome-wide |
siRNA |
RSA P-value |
<0.001 |
SS1P was applied in a "high dose", ≈EC90, 13 ng/ml. Cutoff was derived from data submitted to Pubchem (ID 1117281). Reagent sequences but no ID |
GR00376-A-2 |
6714 |
6714 |
SRC |
|
0.072186587 |
none |
|
|
|
Sensitizers of SS1P-induced immunotoxicity |
Whole-genome RNAi screen highlights components of the endoplasmic reticulum/Golgi as a source of resistance to immunotoxin-mediated cytotoxicity |
Pasetto et al. |
2015 |
25713356 |
Cell line |
KB cells |
Viability |
Luminescence |
Ambion Silencer Select Version 4 |
Genome-wide |
siRNA |
RSA P-value |
<0.001 |
SS1P was applied in a "low dose", ≈EC30, 3 ng/ml. Cutoff was derived from data submitted to PubChem (ID 1117281). Reagent sequences but no ID |
GR00378-A |
6714 |
|
SRC |
|
1.051803352 |
none |
|
|
|
Poliovirus vaccine production |
Engineering Enhanced Vaccine Cell Lines To Eradicate Vaccine-Preventable Diseases: the Polio End Game |
van der Sanden et al. |
2015 |
26581994 |
Cell line |
HEp-2C |
Infection with Attenuated Poliovirus |
ELISA |
Dharmacon |
Genome-wide |
siRNA |
Z-score |
> |
For infection, a single lot of the attenuated Sabin type 2 poliovirus was used for the screen. Gene IDs were not provided, only the gene name/symbol |
|
6714 |
NM_005417 |
SRC |
|
37.977 |
none |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GR00386-A-1 |
6714 |
6714 |
SRC |
|
98.498545060184 |
none |
|
|
|
NOD2 stimulation by MDP |
A genome-wide small interfering RNA (siRNA) screen reveals nuclear factor-κB (NF-κB)-independent regulators of NOD2-induced interleukin-8 (IL-8) secretion. |
Warner et al. |
2014 |
25170077 |
Cell line |
HEK293 stably expressing NOD2 |
Viability |
Luminescence |
Dharmacon |
Genome-wide |
siRNA |
Percentage growth |
Decreased: <70, increased: >120 |
Reagent IDs not provided |
GR00386-A-2 |
6714 |
6714 |
SRC |
|
-64.5 |
none |
|
|
|
MDP-induced IL-8 secretion |
A genome-wide small interfering RNA (siRNA) screen reveals nuclear factor-κB (NF-κB)-independent regulators of NOD2-induced interleukin-8 (IL-8) secretion. |
Warner et al. |
2014 |
25170077 |
Cell line |
HEK293 stably expressing NOD2 |
IL-8 secretion |
ELISA |
Dharmacon |
Genome-wide |
siRNA |
Percent inhibition of IL-8 secretion |
Increased: <-300, Decreased: >60 |
Concentration of IL-8 was measured from cell supernatants by sandwich ELISA. IL-8 values (pg/ml) were normalized to IL-8 secreted in cells treated with RIPK2-specific siRNA (100% inhibition) and non-targeting siRNA (0% inhibition). Secondary validating screen assessed 554 genes whose silencing affected MDP-induced IL-8 secretion in the primary screen. Final validated IL-8 regulators (positive or negative) are listed in the comments column. Reagent IDs not provided |